Screen › Candidate profiles › BSX
Boston Scientific Corp (BSX) — wheel strategy suitability
Where BSX sits as an underlying for selling cash-secured puts and covered calls, and what its own price history says about the risk of being assigned into a falling stock. Snapshot of 3 October 2026.
Boston Scientific Corp (BSX) scores 74 on the Wheel score, which puts it in the preferred band for selling cash-secured puts and covered calls.
The score is carried by its quality (66/100) and held back by valuation (47/100). Growth is deliberately excluded from this score: fast growers tend to carry high implied volatility and gap risk, which is the opposite of what a wheel seller wants. It is not cheap, so assignment would leave you holding a fully priced stock.
It has weekly options, so no liquidity haircut is applied — weeklies let you roll on a shorter cycle and take theta more often.
Over the last 3.0 years it had 2 days with a fall of 10% or more (0.67 a year), a deepest drawdown of -60.6%, and a worst single session of -17.6%. That is in line with the median screened name (0.67 gap-downs a year, -44.9% typical worst drawdown).
Realised volatility runs about 28% annualised. That sits in the range where premium is worth collecting without the stock being wild.
There is no uptrend in the price right now, so assignment would leave you holding something that is not going up.
Score breakdown
| Wheel score | 74 | 0–100 suitability for options selling |
|---|---|---|
| Quality | 66 | ROIC, margins, leverage, accruals |
| Valuation | 47 | cheaper on fwd P/E, EV/EBITDA, FCF yield |
| Margin stability | — | steadier earnings score higher |
| Options listed | Weekly | weekly avoids the liquidity haircut |
| Accounting flags | 0 | −8 points each |
Realised tail risk
Computed from our own daily price history, 2023-10-04 to 2026-10-01 (749 sessions). The Wheel score is built from fundamentals, so these price-derived numbers are an independent check on it, not a restatement of it.
| Days falling 10%+ in one session | 2 | 0.67 a year |
|---|---|---|
| Deepest drawdown | -60.6% | peak to trough |
| Worst single session | -17.6% | |
| Realised volatility | 28% | annualised |
Fundamentals
| Revenue (ttm) | 20,074M USD |
|---|---|
| Revenue CAGR (3y) | 16.5% |
| Net margin | 14.4% |
| Return on equity | 12.0% |
| Share price | $43.23 |
| Days to earnings | — |
| Sector / industry | Healthcare · Medical Devices |
Open the BSX options chain on Yahoo Finance to check live strikes and premium — this page deliberately carries no quotes, because a quote baked into a static page is stale before you read it.
Run the numbers on BSX
Pre-filled with the snapshot price of $43.23 and 30-day realised volatility; add the strike and premium from the live option chain.